On September 4, 2020 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), reported that management will be participating in the following investor conferences this month (Press release, Infinity Pharmaceuticals, SEP 4, 2020, View Source [SID1234564488]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Securities Annual Healthcare Conference

Date:

Wednesday, September 9th

Time:

3:30 pm Eastern Time

Webcast:

View Source

H.C. Wainwright Global Investment Conference

Date:

Tuesday, September 15th

Time:

2:00 pm Eastern Time

Webcast:

View Source

A live webcast of each presentation will be available on the Investors/Media section of Infinity’s website at www.infi.com and will be available for 30 days following the event.

On September 4, 2020 Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, reported its participation in the following upcoming investor conferences (Press release, Fate Therapeutics, SEP 4, 2020, View Source [SID1234564487]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird Global Healthcare Conference on Wednesday, September 9, 2020.
Citi 15th Annual BioPharma Conference on Wednesday, September 9, 2020.
Wells Fargo Healthcare Conference on Thursday, September 10, 2020.
Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 15, 2020.
H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020.
Oppenheimer 30th Annual Healthcare Conference on Tuesday, September 29, 2020.
A live webcast, if recorded, of each presentation will be available through the investor relations section of the Company’s website at www.fatetherapeutics.com. Following each live webcast, an archived replay will be available on the Company’s website.

On September 4, 2020 MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, reported its participation in the following upcoming virtual investor conferences (Press release, MEI Pharma, SEP 4, 2020, View Source [SID1234564486]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 at 2:40 p.m. ET
H.C. Wainwright & Co. 22nd Annual Global Investment Conference on Monday, September 14, 2020 at 12:00 p.m. ET
Cantor Virtual Global Healthcare Conference on Thursday, September 17, 2020 at 4:00 p.m. ET
A live webcast of each presentation providing a company overview and business update can be accessed on the Events & Presentations page of the Investors section of MEI Pharma’s website at View Source An archived replay of the webcast will be available on MEI Pharma’s website for at least 30 days after the live event concludes.

On September 4, 2020 Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported that Ian Taylor, Ph.D., Chief Scientific Officer, will participate in a fireside chat at the Citi 15th Annual BioPharma Virtual Conference on Thursday, September 10 at 2:25 p.m. ET (Press release, Arvinas, SEP 4, 2020, View Source [SID1234564484]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available here and on Arvinas’ website at www.arvinas.com. A replay of the webcast will be archived on Arvinas’ website for 30 days following the presentation.

On September 4, 2020 Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, reported that the company will participate in four upcoming virtual healthcare investor conferences (Press release, Calithera Biosciences, SEP 4, 2020, View Source [SID1234564483]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual Biopharma Virtual Conference. Susan M. Molineaux, Ph.D., the company’s founder, president and chief executive officer, will participate in a panel presentation titled "Precision Targeted Drugs in Oncology," on Wednesday, September 9, 2020, at 11:40 a.m. Eastern Time.

2020 Wells Fargo Virtual Healthcare Conference. Susan M. Molineaux will participate in an analyst moderated meeting on Thursday, September 10, 2020, at 11:20 a.m. Eastern Time.

H.C. Wainwright & Co. 22nd Annual Global Investment Conference. Susan M. Molineaux will present on Wednesday, September 16, 2020, at 9:30 a.m. Eastern Time.

Cantor Virtual Global Healthcare Conference 2020. Susan M. Molineaux will present on Thursday, September 17, 2020, at 2:40 p.m. Eastern Time.
The presentations will be webcast live and also available for replay for up to 30 days following initial presentation in the Investor Relations section at www.calithera.com.